MicroPort CardioFlow Medtech Corporation (2160.HK)

HKD 1.1

(-1.79%)

EBITDA Summary of MicroPort CardioFlow Medtech Corporation

  • MicroPort CardioFlow Medtech Corporation's latest annual EBITDA in 2023 was -386.04 Million CNY , down -8.17% from previous year.
  • MicroPort CardioFlow Medtech Corporation's latest quarterly EBITDA in 2023 FY was N/A , down -8.17% from previous quarter.
  • MicroPort CardioFlow Medtech Corporation reported an annual EBITDA of -347.91 Million CNY in 2022, down -86.17% from previous year.
  • MicroPort CardioFlow Medtech Corporation reported an annual EBITDA of -126.43 Million CNY in 2021, up 22.29% from previous year.
  • MicroPort CardioFlow Medtech Corporation reported a quarterly EBITDA of -78.4 Million CNY for 2023 Q1, up 35.48% from previous quarter.
  • MicroPort CardioFlow Medtech Corporation reported a quarterly EBITDA of -78.4 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of MicroPort CardioFlow Medtech Corporation (2023 - 2018)

Historical Annual EBITDA of MicroPort CardioFlow Medtech Corporation (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -386.04 Million CNY -8.17%
2022 -347.91 Million CNY -86.17%
2021 -126.43 Million CNY 22.29%
2020 -227.43 Million CNY -49.76%
2019 -118.33 Million CNY -92.1%
2018 -56.55 Million CNY 0.0%

Peer EBITDA Comparison of MicroPort CardioFlow Medtech Corporation

Name EBITDA EBITDA Difference
Vincent Medical Holdings Limited 104.43 Million HKD 469.665%